Latest Articles
-
2026 Health Care Outlook: Micah Cost, PQA
-
PQA Appoints Individuals to Serve on 2026 Panels
PQA has appointed individuals from member organizations to serve on the 2026 PQA Measure Update Panel (MUP) and Quality Metrics Expert Panel (QMEP). The panelists self-nominated and were selected by PQA staff to create a balanced group that represents PQA’s membership and includes relevant expertise. Measure Update Panel (MUP) The MUP is a select group […] -
PQA Prioritizes Health Plan Measure Concepts for Future Development
Early in the measure life cycle, PQA solicits multi-stakeholder input to evaluate and prioritize health plan measure concepts for future development. To support measure conceptualization in 2025, PQA convened a Measure Concept Advisory Group (MCAG) and conducted a public comment period to inform future measure development, with a particular focus on addressing meaningful gaps in medication use quality while ensuring measure concepts are evidence-based and […] -
PQA Quality Leadership Program Expanded in 2025
The PQA Quality Leadership Program expanded in 2025 to increase opportunities for all professionals at PQA member organizations and students to hone their skills in medication use quality and gain valuable knowledge about PQA’s measure development process and the measure life cycle. Eleven individuals were selected to shadow the Quality Metrics Expert Panel or the Measure Update […] -
PQA Releases Social Determinants of Health Resource Guide Companion
Companion Provides Insights on Partnerships for Improving Medication Use Quality Alexandria, Va. (December 29, 2025) – The Pharmacy Quality Alliance (PQA) has released a PQA Social Determinants of Health (SDOH) Resource Guide Companion, which provides insights on key characteristics of effective partnerships among pharmacies, other health care organizations and community organizations to address SDOH barriers affecting medication […] -
Five for Friday December 19: Celebrating Success in Advancing Medication Use Quality
The PQA Board of Directors has adopted the goals and objectives of PQA's next strategic plan, Blueprint PQA 2030, which will guide our work from 2026 through 2030. This follows our highly successful Leadership Summit, where PQA members provided insights and guidance on the strategies and tactics that will be important for our success in the coming years. -
Five for Friday December 5: Celebrating Success in Advancing Medication Use Quality
A research partnership between PQA, Merck, and the University of Mississippi focused on three PQA adherence measures to continue to monitor their impact. The project examined Medicare Advantage enrollees who were taking either diabetes, renin-angiotensin system antagonist, or statin medications. The study found that higher proportion of days covered (PDC) in one year was associated […] -
Better Adherence Lowers Payer Medical Costs
A research partnership between PQA, Merck, and the University of Mississippi focused on three PQA adherence measures to continue to monitor their impact. Using administrative claims data from Optum’s de-identified Clinformatics® Data Mart Database, the project examined Medicare Advantage enrollees who were taking either diabetes, renin-angiotensin system antagonist (RASA), or statin medications. Findings suggest the average patient-level adherence rate was between 84%-89% across the three medication classes using a modified […] -
Five for Friday November 21: Celebrating Success in Advancing Medication Use Quality
PQA will launch a new Patient Advisory Council in 2026. This council will advise PQA on what matters most to patients, their families and caregivers as it relates to safe, effective and appropriate medication use. PQA invites patients, caregivers, and patient advocates to consider submitting nominations. -
Five for Friday November 7: Celebrating Success in Advancing Medication Use Quality
We are excited to welcome attendees next week to the 2025 PQA Leadership Summit and PQA Convenes: Artificial Intelligence in Quality Medication Use at the Renaissance Arlington Capital View Hotel in Arlington, Va. This year's summit will focus on Blueprint PQA 2030, PQA's next strategic plan.
PQA In the News
-
Making Medication Management Services Measurable and Visible
-
PQA’s quality roadmap: Micah Cost on the next era of medication quality measurement
-
Focusing Quality Measures on Outcomes and Patient Experience
-
Value-Based Pharmacy Model Helps Boost Care Quality
-
PQA presents Quality Awards to 10 Medicare plan contracts for high achievement in medication quality measures
Request a PQA Expert
For members of the media or who wish to speak with an expert source on quality, please contact:
Download Media Materials
For PQA logos, images and other communications collateral, please contact:
Leading the Conversation About Medication Quality

“Quality medication use is essential to value-based, person-centered care. Through connection, collaboration, and consensus, PQA drives improvements to promote the best medication-related care and outcomes for patients.”
Micah Cost, PharmD, MS, CAE, Chief Executive Officer
Stay Informed
Get the latest PQA news and events delivered to your inbox.


